Screener
Oruka Therapeutics, Inc. ORKA Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 4:01 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001213900-26-055769
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Operating expenses: | ||
| Research and development(1) | $29,145 | $19,925 |
| General and administrative(2) | 7,289 | 5,161 |
| Total operating expenses | 36,434 | 25,086 |
| Loss from operations | (36,434) | (25,086) |
| Other income (expense): | ||
| Interest income | 4,606 | 4,092 |
| Other income (expense), net | 8 | (5) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Oruka Therapeutics, Inc.'s other operating expenses?
- Oruka Therapeutics, Inc. (ORKA) reported other operating expenses of $36.43M in Q1 2026.
- How has Oruka Therapeutics, Inc.'s other operating expenses changed year-over-year?
- Oruka Therapeutics, Inc.'s other operating expenses increased by 45.2% year-over-year, from $25.09M to $36.43M.
- What is the long-term trend for Oruka Therapeutics, Inc.'s other operating expenses?
- Over 4 years (2021 to 2025), Oruka Therapeutics, Inc.'s other operating expenses has grown at a 58.5% compound annual growth rate (CAGR), from $19.34M to $122.05M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.
Ask your AI about Oruka Therapeutics, Inc.'s other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude